Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 43(6): 585-592, June 2010. ilus, tab
Article Dans Anglais | LILACS | ID: lil-548274

Résumé

The effect of physical exercise on the treatment of depressive elderly adults has not been investigated thus far in terms of changes in cortical hemispheric activity. The objective of the present study was to identify changes in depressive symptoms, quality of life, and cortical asymmetry produced by aerobic activity. Elderly subjects with a diagnosis of major depressive disorder (DSM-IV) were included. Twenty patients (70 percent females, 71 ± 3 years) were divided into an exercise group (pharmacological treatment plus aerobic training) and a control group (undergoing pharmacological treatment) in a quasi-experimental design. Pharmacological treatment was maintained stable throughout the study (antidepressants and anxiolytics). Subjects were evaluated by depression scales (Beck Depression Inventory, Hamilton Depression Rating Scale, Montgomery-Asberg Depression Rating Scale) and the Short Form Health Survey-36, and electroencephalographic measurements (frontal and parietal alpha asymmetry) before and after 1 year of treatment. After 1 year, the control group showed a decrease in cortical activity on the right hemisphere (increase of alpha power), which was not observed in the exercise group. The exercise group showed a significant decrease of depressive symptoms, which was not observed in the control group. This result was also accompanied by improved treatment response and remission rate after 1 year of aerobic exercise associated with treatment. This study provides support for the effect of aerobic training on alpha activity and on depressive symptoms in elderly patients. Exercise facilitates the treatment of depressive elderly adults, leading to clinical and physical improvement and protecting against a decrease in cortical activity.


Sujets)
Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Rythme alpha , Trouble dépressif majeur/thérapie , Traitement par les exercices physiques/méthodes , Qualité de vie , Anxiolytiques/usage thérapeutique , Antidépresseurs/usage thérapeutique , Association thérapeutique , Trouble dépressif majeur/psychologie , Électroencéphalographie , Études de suivi , Échelles d'évaluation en psychiatrie
2.
Braz. j. med. biol. res ; 38(12): 1835-1846, Dec. 2005. tab
Article Dans Anglais | LILACS | ID: lil-417192

Résumé

A chimeric yellow fever (YF)-dengue serotype 2 (dengue 2) virus was constructed by replacing the premembrane and envelope genes of the YF 17D virus with those from dengue 2 virus strains of Southeast Asian genotype. The virus grew to high titers in Vero cells and, after passage 2, was used for immunogenicity and attenuation studies in rhesus monkeys. Subcutaneous immunization of naive rhesus monkeys with the 17D-D2 chimeric virus induced a neutralizing antibody response associated with the protection of 6 of 7 monkeys against viremia by wild-type dengue 2 virus. Neutralizing antibody titers to dengue 2 were significantly lower in YF-immune animals than in YF-naive monkeys and protection against challenge with wild-type dengue 2 virus was observed in only 2 of 11 YF-immune monkeys. An anamnestic response to dengue 2, indicated by a sharp increase of neutralizing antibody titers, was observed in the majority of the monkeys after challenge with wild-type virus. Virus attenuation was demonstrated using the standard monkey neurovirulence test. The 17D-D2 chimera caused significantly fewer histological lesions than the YF 17DD virus. The attenuated phenotype could also be inferred from the limited viremias compared to the YF 17DD vaccine. Overall, these results provide further support for the use of chimeric viruses for the development of a new live tetravalent dengue vaccine.


Sujets)
Animaux , Mâle , Femelle , Anticorps antiviraux/biosynthèse , Virémie/immunologie , Virus de la dengue/immunologie , Virus de la fièvre jaune/immunologie , Séquence d'acides aminés , Anticorps antiviraux/immunologie , Chlorocebus aethiops , Macaca mulatta , Données de séquences moléculaires , Tests de neutralisation , Recombinaison génétique , RT-PCR , Cellules Vero , Virus de la dengue/génétique , Virus de la fièvre jaune/génétique
SÉLECTION CITATIONS
Détails de la recherche